Investigator Initiated Studies (IIS) Grants Program

About this program

Tris Pharma’s Investigator-Initiated Studies (IIS) Grants Program supports original, investigator-led research to advance scientific knowledge and improve patient outcomes, funding pre-clinical, post-mortem, in vitro and human clinical studies in areas such as vascular access, anesthesia, emergency medicine, cardiac care, interventional access, urology, and surgical care. Applicants must be qualified by training and experience, must not be Tris employees or excluded/debarred from healthcare programs, must be the originator and author of the protocol, and must conduct the study in accordance with applicable laws and GCP/GLP standards; submissions are preferred in English. Required materials include a current CV, a research proposal (hypothesis, study design, inclusion/exclusion criteria, recruitment plan), detailed budget and product documentation where applicable, and the completed IIS Grant Request Form; proposals are reviewed on scientific merit and available funding, and Tris complies with U.S. Open Payments reporting.